These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17317696)

  • 1. Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I.
    Cheng B; Liu IF; Tse-Dinh YC
    J Antimicrob Chemother; 2007 Apr; 59(4):640-5. PubMed ID: 17317696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial topoisomerase I as a target for discovery of antibacterial compounds.
    Tse-Dinh YC
    Nucleic Acids Res; 2009 Feb; 37(3):731-7. PubMed ID: 19042977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of anziaic acid, a lichen depside from Hypotrachyna sp., as a new topoisomerase poison inhibitor.
    Cheng B; Cao S; Vasquez V; Annamalai T; Tamayo-Castillo G; Clardy J; Tse-Dinh YC
    PLoS One; 2013; 8(4):e60770. PubMed ID: 23593306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors.
    Yu X; Zhang M; Annamalai T; Bansod P; Narula G; Tse-Dinh YC; Sun D
    Eur J Med Chem; 2017 Jan; 125():515-527. PubMed ID: 27689733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial cell killing mediated by topoisomerase I DNA cleavage activity.
    Cheng B; Shukla S; Vasunilashorn S; Mukhopadhyay S; Tse-Dinh YC
    J Biol Chem; 2005 Nov; 280(46):38489-95. PubMed ID: 16159875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fluorescence-Based Assay for Identification of Bacterial Topoisomerase I Poisons.
    Annamalai T; Cheng B; Keswani N; Tse-Dinh YC
    Methods Mol Biol; 2018; 1703():259-268. PubMed ID: 29177747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II).
    Cheng B; Annamalai T; Sandhaus S; Bansod P; Tse-Dinh YC
    PLoS One; 2015; 10(3):e0120022. PubMed ID: 25798600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
    Tse-Dinh YC
    Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The strictly conserved Arg-321 residue in the active site of Escherichia coli topoisomerase I plays a critical role in DNA rejoining.
    Narula G; Annamalai T; Aedo S; Cheng B; Sorokin E; Wong A; Tse-Dinh YC
    J Biol Chem; 2011 May; 286(21):18673-80. PubMed ID: 21478161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.
    Tiwari PB; Chapagain PP; Seddek A; Annamalai T; Üren A; Tse-Dinh YC
    ChemMedChem; 2020 Apr; 15(7):623-631. PubMed ID: 32043806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Mg2+ binding and DNA religation by bacterial topoisomerase I via introduction of an additional positive charge into the active site region.
    Sorokin EP; Cheng B; Rathi S; Aedo SJ; Abrenica MV; Tse-Dinh YC
    Nucleic Acids Res; 2008 Aug; 36(14):4788-96. PubMed ID: 18653534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents.
    Nimesh H; Sur S; Sinha D; Yadav P; Anand P; Bajaj P; Virdi JS; Tandon V
    J Med Chem; 2014 Jun; 57(12):5238-57. PubMed ID: 24856410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation adjacent to the active site tyrosine can enhance DNA cleavage and cell killing by the TOPRIM Gly to Ser mutant of bacterial topoisomerase I.
    Cheng B; Sorokin EP; Tse-Dinh YC
    Nucleic Acids Res; 2008 Feb; 36(3):1017-25. PubMed ID: 18096618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase I function during Escherichia coli response to antibiotics and stress enhances cell killing from stabilization of its cleavage complex.
    Liu IF; Sutherland JH; Cheng B; Tse-Dinh YC
    J Antimicrob Chemother; 2011 Jul; 66(7):1518-24. PubMed ID: 21486853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases.
    Klemm M; Cheng C; Cassell G; Shuman S; Segall AM
    J Mol Biol; 2000 Jun; 299(5):1203-16. PubMed ID: 10873446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of vaccinia virus DNA topoisomerase I that stabilize the cleavage complex.
    Gupta M; Zhu CX; Tse-Dinh YC
    J Biol Chem; 1994 Jan; 269(1):573-8. PubMed ID: 8276853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assay for the detection of bacterial DNA gyrase inhibitors.
    Osburne MS; Maiese WM; Greenstein M
    J Antibiot (Tokyo); 1993 Nov; 46(11):1764-6. PubMed ID: 8270502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase as target for antibacterial and anticancer drug discovery.
    Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of type IA topoisomerase by a monoclonal antibody through perturbation of DNA cleavage-religation equilibrium.
    Leelaram MN; Bhat AG; Hegde SM; Manjunath R; Nagaraja V
    FEBS J; 2012 Jan; 279(1):55-65. PubMed ID: 22008463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
    Marx G; Zhou H; Graves DE; Osheroff N
    Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.